Edition:
United Kingdom

People: Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

25.02USD
17 Jul 2019
Change (% chg)

$-0.55 (-2.15%)
Prev Close
$25.57
Open
$25.68
Day's High
$25.68
Day's Low
$24.78
Volume
161,830
Avg. Vol
348,078
52-wk High
$27.99
52-wk Low
$1.94

Tabuteau, Herriot 

Dr. Herriot Tabuteau, M.D. Chief Executive Officer, President, Chairman of the Board of the Company. Dr. Tabuteau has served as our founder, Chief Executive Officer, and Chairman of our board of directors since our founding in January 2012. He is also the founder of Antecip Capital LLC (formerly Versant Capital Management LLC), one of our principal stockholders, for which Dr. Tabuteau has been the managing member since 2003. Dr. Tabuteau is also the managing member of Antecip Bioventures II LLC. Prior to founding our company, Dr. Tabuteau was a Senior Analyst and Partner at Healthco/S.A.C. Capital (now known as HealthCor) where he was responsible for the biotechnology, genomics, and instrumentation portfolios. Previously, Dr. Tabuteau was the healthcare analyst at Kingdon Capital. Prior to that position, Dr. Tabuteau was a Senior Research Analyst at Banc of America Securities covering the hospital supplies sector. Prior to Banc of America, Dr. Tabuteau was part of the healthcare investment banking group at Goldman Sachs. Dr. Tabuteau earned his M.D. from Yale University School of Medicine and his Bachelor of Arts in molecular biology and biochemistry from Wesleyan University.

Basic Compensation

Total Annual Compensation, USD 435,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 688,352
Fiscal Year Total, USD 1,123,350

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --